How much revenue will Radionetics generate from the Lilly deal by end of 2025? | Categorical | | | 6 months ago | |
Will Lilly acquire Radionetics Oncology by end of 2024? | Binary | | | 6 months ago | |
Will Radionetics receive FDA approval for a new radiopharmaceutical by mid-2025? | Binary | | | 6 months ago | |
Will Lilly announce another strategic agreement with a biotech company by end of 2024? | Binary | | | 6 months ago | |
Publication venue for first joint research paper by Eli Lilly and OpenAI? | Categorical | | | 6 months ago | |
First major milestone of Eli Lilly's AI-driven drug discovery program? | Categorical | | | 6 months ago | |
Eli Lilly announces AI-developed drug candidate by end of 2024? | Binary | | | 6 months ago | |
Eli Lilly and OpenAI publish joint research by September 30, 2024? | Binary | | | 6 months ago | |
Eli Lilly's AI-driven antimicrobial project gets clinical trial approval by end of 2024? | Binary | | | 6 months ago | |
First AI-developed drug candidate from Eli Lilly and OpenAI collaboration? | Categorical | | | 6 months ago | |
How many drug-resistant bacteria strains will Eli Lilly and OpenAI target by June 30, 2024? | Categorical | | | 6 months ago | |
How many new partnerships will Eli Lilly and OpenAI announce in the field of drug discovery by end of 2024? | Categorical | | | 6 months ago | |
Will the FDA approve a new antimicrobial drug by Eli Lilly and OpenAI by end of 2024? | Binary | | | 6 months ago | |
Will there be a peer-reviewed study on a new antimicrobial by Eli Lilly and OpenAI by June 30, 2024? | Binary | | | 6 months ago | |
Will Eli Lilly's stock price increase by 10% or more by end of 2024 due to the collaboration with OpenAI? | Binary | | | 6 months ago | |
Will Eli Lilly and OpenAI identify a novel antimicrobial drug candidate by March 31, 2024? | Categorical | | | 6 months ago | |
Development delay announced by Aktis Oncology or Eli Lilly in 2024? | Binary | | | 7 months ago | |
Total milestone payments to Aktis Oncology in 2024 | Categorical | | | 7 months ago | |
Clinical trial stage for Aktis Oncology’s anticancer drugs by end of 2024 | Categorical | | | 7 months ago | |
Eli Lilly acquires additional stake in Aktis Oncology in 2024? | Binary | | | 7 months ago | |
Aktis Oncology achieves first milestone payment in 2024? | Binary | | | 7 months ago | |
Will the collaboration successfully complete a phase 1 clinical trial of a new anticancer radiopharmaceutical by the end of 2025? | Binary | | | 7 months ago | |
How many new anticancer radiopharmaceuticals will enter clinical trials by the end of 2025? | Categorical | | | 7 months ago | |
Will Aktis Oncology and Eli Lilly terminate their collaboration by the end of 2025? | Binary | | | 7 months ago | |
Will FDA issue warning or ban on compounded GLP-1 drugs by end of 2025? | Binary | | | 12 days ago | |
Will Zepbound price drop by 20% or more by June 30, 2025? | Binary | | | 12 days ago | |
Will Hims & Hers Health stock price fall below $5 by end of 2024? | Binary | | | 4 months ago | |
Will Eli Lilly's Zepbound sales exceed $500 million by the end of Q4 2024? | Binary | | | 4 months ago | |
Will Morphic's lead program receive FDA approval by December 31, 2025? | Binary | | | 6 months ago | |
Which clinical trial phase will Radionetics' leading radiopharmaceutical reach by end of 2025? | Categorical | | | 6 months ago | |
Royalty rates for Aktis Oncology’s anticancer drug sales by end of 2024 | Categorical | | | 7 months ago | |
Will Aktis Oncology receive the next milestone payment from Eli Lilly by the end of 2025? | Binary | | | 7 months ago | |
What will be the revenue from sales of anticancer radiopharmaceuticals developed by Aktis Oncology and Eli Lilly by the end of 2025? | Categorical | | | 7 months ago | |
Will Ro-Lilly partnership boost Zepbound prescriptions by 50% by end of 2025? | Binary | | | 12 days ago | |
750 New Jobs Created at Eli Lilly Wisconsin Plant by End of 2026? | Binary | | | 18 days ago | |
Eli Lilly $3B Wisconsin Plant Expansion Completed by End of 2026? | Binary | | | 18 days ago | |
Eli Lilly Global Manufacturing Investment Total by End of 2026? | Categorical | | | 18 days ago | |
Eli Lilly Increases Production Capacity for Diabetes and Obesity Medicines by End of 2026? | Binary | | | 18 days ago | |
Will Eli Lilly exercise an option for additional collaboration with Insitro by 2025? | Binary | | | 2 months ago | |
Will Insitro's first drug from Eli Lilly collaboration enter clinical trials by 2026? | Binary | | | 2 months ago | |
Which regulatory authority will first approve a drug from Insitro-Eli Lilly collaboration by 2028? | Categorical | | | 2 months ago | |
Will Insitro achieve a milestone payment from Eli Lilly collaboration by 2025? | Binary | | | 2 months ago | |
What will be Eli Lilly's revenue growth rate for the fiscal year 2024? | Categorical | | | 3 months ago | |
What will be Eli Lilly's stock price performance in 2024? | Categorical | | | 3 months ago | |
Will Eli Lilly complete the $1.8 billion expansion of its Raheen, Limerick facility by December 31, 2024? | Binary | | | 3 months ago | |
Will Eli Lilly's market cap exceed $900 billion by March 31, 2025? | Binary | | | 3 months ago | |
Will Eli Lilly create 150 new jobs at its Raheen, Limerick facility by June 30, 2025? | Binary | | | 3 months ago | |
Will Eli Lilly's stock price exceed $600 by end of 2024? | Binary | | | 4 months ago | |
What will Eli Lilly's Q4 2024 revenue be? | Categorical | | | 4 months ago | |
Will Eli Lilly's market share in weight-loss drugs exceed 30% by end of 2024? | Binary | | | 4 months ago | |
Which company will enter into a new partnership with Illumina for oncology diagnostics by the end of 2024? | Categorical | | | 4 months ago | |
Which company will see the highest stock price increase by the end of 2024 due to the FDA approval of Illumina's assay? | Categorical | | | 4 months ago | |
Will Bayer's Vitrakvi prescriptions increase significantly in the US by the end of Q1 2025? | Binary | | | 4 months ago | |
Will Lilly's Retevmo receive additional FDA approvals for new indications by August 2025? | Binary | | | 4 months ago | |
Will Illumina's TruSight Oncology Comprehensive assay be adopted by more than 50 major US hospitals by mid-2025? | Binary | | | 4 months ago | |
What will be the price of Eli Lilly's stock by the end of 2024? | Categorical | | | 4 months ago | |
Will Hims & Hers Health stock recover to its pre-announcement level by the end of 2024? | Binary | | | 4 months ago | |
Will Eli Lilly complete the acquisition of Morphic Holding by December 31, 2024? | Binary | | | 6 months ago | |
Will Eli Lilly's stock price increase by 10% or more by March 31, 2025, following the acquisition of Morphic Holding? | Binary | | | 6 months ago | |
How many additional investments in radiopharmaceuticals will Eli Lilly make by the end of 2025? | Categorical | | | 7 months ago | |
How many new partnerships will Eli Lilly form for Zepbound by end of 2025? | Categorical | | | 12 days ago | |
What will be the market share change between Zepbound and Wegovy by end of 2025? | Categorical | | | 12 days ago | |
Region Most Impacted by Eli Lilly Wisconsin $3B Investment by End of 2026? | Categorical | | | 18 days ago | |
Primary Benefit of Eli Lilly Wisconsin $3B Investment by End of 2026? | Categorical | | | 18 days ago | |
What will be the first therapeutic area targeted by Insitro's drug from Eli Lilly collaboration by 2026? | Categorical | | | 2 months ago | |
What will be the primary AI technology in Insitro's drug development from Eli Lilly collaboration by 2025? | Categorical | | | 2 months ago | |
Which will be the first drug produced at the expanded Raheen, Limerick facility by June 30, 2025? | Categorical | | | 3 months ago | |
How will Zepbound price reduction impact patient access by end of 2024? | Categorical | | | 4 months ago | |
What will be the impact on Eli Lilly's market share in weight-loss drugs by end of 2024? | Categorical | | | 4 months ago | |
Which cancer type will see the most significant treatment advancements by the end of 2024 due to the use of Illumina's TruSight Oncology Comprehensive assay? | Categorical | | | 4 months ago | |
Which company will be the leader in the weight-loss drug market by the end of 2024? | Categorical | | | 4 months ago | |
What will be Eli Lilly's Zepbound market share in the weight-loss drug market by the end of Q1 2025? | Categorical | | | 4 months ago | |
Will Eli Lilly face any legal challenges regarding Zepbound pricing by mid-2024? | Binary | | | 4 months ago | |
What will be the impact of Morphic acquisition on Eli Lilly's immunology pipeline by December 31, 2025? | Categorical | | | 6 months ago | |
What type of company will Eli Lilly announce as their next major acquisition by December 31, 2024? | Categorical | | | 6 months ago | |
What will be the outcome of Morphic Holding's lead program clinical trial results by June 30, 2025? | Categorical | | | 6 months ago | |
What major milestone will Radionetics achieve by end of 2024? | Categorical | | | 6 months ago | |
How will public opinion on GLP-1 drug affordability change by end of 2025? | Categorical | | | 12 days ago | |
